Immune-related histologic phenotype in pretreatment tumour biopsy predicts the efficacy of neoadjuvant anti-PD-1 treatment in squamous lung cancer

BACKGROUND: Although neoadjuvant anti-PD-1 immunotherapies have shown good efficacy in non-small cell lung cancer (NSCLC) patients, there is still a lack of effective predictive markers. We aimed to develop a pretreatment histologic scoring system to predict the efficacy of neoadjuvant immunotherapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Pei, Guo, Changyuan, Li, Lin, Ling, Yun, Guo, Lei, Ying, Jianming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9594940/
https://www.ncbi.nlm.nih.gov/pubmed/36280845
http://dx.doi.org/10.1186/s12916-022-02609-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9594940/
https://www.ncbi.nlm.nih.gov/pubmed/36280845
http://dx.doi.org/10.1186/s12916-022-02609-5

Ejemplares similares